Hyperhaemolysis in sickle cell disease - An unusual and potentially life-threatening complication

Medical Journal of Australia

Volumn 192, Issue 5, 2010, Pages 281-282

  Stokes, Ian C ^a   Downie, Peter A ^a   Wood, Erica M ^b   Bowden, Donald K ^c   Monagle, Paul T ^a   Barnes, Chris D ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; HEMOGLOBIN; IMMUNOGLOBULIN; MANNITOL; METHYLPREDNISOLONE; IMMUNOLOGIC FACTOR;

ANALGESIA; ARTICLE; AUSTRALIA; CASE REPORT; CHILD; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; JAUNDICE; MALE; RETICULOCYTE COUNT; SCHOOL CHILD; SICKLE CELL ANEMIA; BLOOD TRANSFUSION; IMMUNOLOGY; PHYSIOLOGY; RECURRENT DISEASE;

ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; RECURRENCE;

EID: 77950608668     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03509.x     Document Type: Article

References (11)

1. Australian Bureau of Statistics. 2006 Census tables: Australia. Canberra: ABS, 2007.
2. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997; 37: 382-392. (Pubitemid 27193551)
3. Talano JA, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003; 111 (6 Pt 1): e661-e665.
4. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006; 46: 105-110.
5. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002; 42: 37-43.
6. Grainger JD, Makar Y, McManus A, Wynn R. Refractory hyperhaemolysis in a patient with beta-thalassaemia major. Transfus Med 2001; 11: 55-57. (Pubitemid 32180323)
7. Treleaven JG, Win N. Hyperhaemolysis syndrome in a patient with myelofibrosis. Hematology 2004; 9: 147-149.
8. Win N, Yeghen T, Needs M, et al. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004; 9: 433-436. (Pubitemid 40123596)
9. King KE, Shirey RS, Lankiewicz MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997; 37: 376-381.
10. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997; 37: 357-361. (Pubitemid 27193547)
11. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001; 41: 323-328. (Pubitemid 32238528)